An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptomatic Management of Myotonia in Adult Patients with Non-dystrophic Myotonic Disorders

10/11/2020
06/03/2026
EU PAS number:
EUPAS37943
Study
Ongoing
Documents
Study protocol
Initial protocol
English (441.82 KB - PDF) View document
Study results
Study report
Other information